ClinicalTrials.Veeva

Menu

National Register of Oesophageal Atresia (REGATE)

U

University Hospital, Lille

Status

Enrolling

Conditions

Esophageal Atresia

Treatments

Other: data collection

Study type

Observational

Funder types

Other

Identifiers

NCT02883725
08.297 (Other Identifier)
Reg 2008
908362 (Other Identifier)

Details and patient eligibility

About

The esophageal atresia is a group of birth defects including a break in continuity of the esophagus with or without persistent communication with the trachea (tracheoesophageal fistula), sometimes associated (from 50%) of other malformations (heart, kidney, digestive ...).

The current prognosis for this ailment is good. However he persists a mortality (<10%) and significant morbidity, firstly related malformations (heart, kidney, for example), and secondly with particularly difficult anatomical forms (Forms long defect) .

The prevalence of this condition is estimated to be 1/2500 in 3000 live births, making an estimated ± 2,500 new cases over to 10 years in France.

The current project aims to set up a national registry (Metropolitan France and Dom Tom) to measure the prevalence of esophageal atresia among live births, phenotypic characteristics, the circumstances of their diagnosis, and their initial future at short-term during the first year of life, at which time occurs the vast majority of deaths and complications in this disease.

Enrollment

2,500 estimated patients

Sex

All

Ages

Under 1 year old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • To be born in France
  • To have a esophageal atresia

Exclusion criteria

  • To be born abroad

Trial design

2,500 participants in 1 patient group

Esophageal atresia
Treatment:
Other: data collection

Trial contacts and locations

37

Loading...

Central trial contact

Frédéric Gottrand, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems